Kennedy’s Rally Highlights Growing Opposition to Vaccines and Big Agriculture Ahead of 2026 Midterms
On Wednesday night in Clive, Iowa, a gathering of Make America Healthy Again activists and…
Newswire
AAV Gene Therapies Demand New Strategies for Sustainable Development
Adeno-associated virus (AAV) gene therapies have transformed the treatment landscape for rare and genetic diseases,…
Hamburg Hosts 2026 European Gene Therapy Conference
HAMBURG—The historic German port city of Hamburg is playing host to the European Society of…
Adial Pharmaceuticals Rebrands as Azora Therapeutics Ahead of Planned Clinical Trial
Adial Pharmaceuticals has officially rebranded as Azora Therapeutics, with Matt Davidson appointed as president and…
Vertex Pharmaceuticals Plans New Research Facility at Harwell Science Campus
Vertex Pharmaceuticals plans to establish a 155,000-square-foot research facility at the Harwell Science and Innovation…
EMA Office Closure on All Souls’ Day, 2 November
The European Medicines Agency (EMA) will be closed on Monday, 2 November, in observance of…
UK Budget Light on Life Sciences but More Doors Open for Biotech Startups
In a recent announcement, the UK government unveiled its Autumn Budget, which has drawn a…
Cellares and GenomeFrontier to Assess Automated GF-CART01 Production
Cellares and GenomeFrontier Therapeutics have announced a collaboration to evaluate the automated manufacturing of GF-CART01,…
Viatris’ Wakix Receives Japanese Approval for OSAS and Narcolepsy Treatment
Japan’s Ministry of Health, Labour and Welfare has granted approval for Viatris’ Wakix, a significant…
FDA Identifies New Safety Signals in Adverse Event Monitoring for Q1 2026
During the first quarter of 2026, the FDA’s Adverse Event Monitoring System (AEMS) reported new…